Literature DB >> 12915550

Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein.

Melanie M Brinkmann1, Mark Glenn, Lucille Rainbow, Arnd Kieser, Cornelia Henke-Gendo, Thomas F Schulz.   

Abstract

The K15 gene of Kaposi's sarcoma-associated herpesvirus (also known as human herpesvirus 8) consists of eight alternatively spliced exons and has been predicted to encode membrane proteins with a variable number of transmembrane regions and a common C-terminal cytoplasmic domain with putative binding sites for SH2 and SH3 domains, as well as for tumor necrosis factor receptor-associated factors. These features are reminiscent of the latent membrane proteins LMP-1 and LMP2A of Epstein-Barr virus and, more distantly, of the STP, Tip, and Tio proteins of the related gamma(2)-herpesviruses herpesvirus saimiri and herpesvirus ateles. These viral membrane proteins can activate a number of intracellular signaling pathways. We have therefore examined the abilities of different K15-encoded proteins to initiate intracellular signaling. We found that a 45-kDa K15 protein derived from all eight K15 exons and containing 12 predicted transmembrane domains in addition to the cytoplasmic domain activated the Ras/mitogen-activated protein kinase (MAPK) and NF-kappaB pathways, as well as (more weakly) the c-Jun N-terminal kinase/SAPK pathway. Activation of the MAPK and NF-kappaB pathways required phosphorylation of tyrosine residue 481 within a putative SH2-binding site (YEEVL). This motif was phosphorylated by the tyrosine kinases Src, Lck, Yes, Hck, and Fyn. The region containing the YEEVL motif interacted with tumor necrosis factor receptor-associated factor 2 (TRAF-2), and a dominant negative TRAF-2 mutant inhibited the K15-mediated activation of the Ras/MAPK pathway, suggesting the involvement of TRAF-2 in the initiation of these signaling routes. In contrast, several smaller K15 protein isoforms activated these pathways only weakly. All of the K15 isoforms tested were, however, localized in lipid rafts, suggesting that incorporation into lipid rafts is not sufficient to initiate signaling. Additional regions of K15, located presumably in exons 2 to 5, may therefore contribute to the activation of these pathways. These findings illustrate that the 45-kDa K15 protein engages pathways similar to LMP1, LMP2A, STP, Tip, and Tio but combines functional features that are separated between LMP1 and LMP2A or STP and Tip.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915550      PMCID: PMC187392          DOI: 10.1128/jvi.77.17.9346-9358.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8.

Authors:  C Blasig; C Zietz; B Haar; F Neipel; S Esser; N H Brockmeyer; E Tschachler; S Colombini; B Ensoli; M Stürzl
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

Authors:  A G Eliopoulos; L S Young
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

3.  Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice.

Authors:  C Boshoff; S J Gao; L E Healy; S Matthews; A J Thomas; L Coignet; R A Warnke; J A Strauchen; E Matutes; O W Kamel; P S Moore; R A Weiss; Y Chang
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

4.  Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Lee; R Veazey; K Williams; M Li; J Guo; F Neipel; B Fleckenstein; A Lackner; R C Desrosiers; J U Jung
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

5.  STP and Tip are essential for herpesvirus saimiri oncogenicity.

Authors:  S M Duboise; J Guo; S Czajak; R C Desrosiers; J U Jung
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

Authors:  O Gires; U Zimber-Strobl; R Gonnella; M Ueffing; G Marschall; R Zeidler; D Pich; W Hammerschmidt
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

7.  The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.

Authors:  K M Izumi; E D Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.

Authors:  A Kieser; E Kilger; O Gires; M Ueffing; W Kolch; W Hammerschmidt
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

9.  Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Authors:  M F Favata; K Y Horiuchi; E J Manos; A J Daulerio; D A Stradley; W S Feeser; D E Van Dyk; W J Pitts; R A Earl; F Hobbs; R A Copeland; R L Magolda; P A Scherle; J M Trzaskos
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.

Authors:  M Kashiwada; Y Shirakata; J I Inoue; H Nakano; K Okazaki; K Okumura; T Yamamoto; H Nagaoka; T Takemori
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

View more
  68 in total

1.  Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.

Authors:  Marcel Pietrek; Melanie M Brinkmann; Ilona Glowacka; Anette Enlund; Anika Hävemeier; Oliver Dittrich-Breiholz; Michael Kracht; Marc Lewitzky; Kalle Saksela; Stephan M Feller; Thomas F Schulz
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion.

Authors:  Michael B Gill; Jo-Ellen Murphy; Joyce D Fingeroth
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Hongyi Pan; Seungmin Yoo; Shou-Jiang Gao
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 6.  Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Authors:  Ethel Cesarman
Journal:  Cancer Lett       Date:  2011-04-13       Impact factor: 8.679

7.  Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Adetola Olalekan Ajibade; Fengchun Ye; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2007-10-26       Impact factor: 3.616

8.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 9.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

Review 10.  Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.

Authors:  Fang Wei; Qing Zhu; Ling Ding; Qing Liang; Qiliang Cai
Journal:  Virol Sin       Date:  2016-09-12       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.